29 April 2009
Workshop on Cancer Genomics
Scientists from Japan, Australia and Spain speak at the IMPPC
The workshop on Cancer Genomics, organized on 29 April by Manuel Perucho, Director of the IMPPC was an opportunity for leading scientists from three continents to discuss their own work and studies they are carrying out in collaboration.
Jun Yokota, PhD, Biology Division, National Cancer Center Research Institute, Tokyo, Japan, gave a talk entitled: Genes for susceptibility of Lung cancer. Dr. Rafael Rosell, Institut Català d'Oncologia (ICO), IGTP, Hospital Universitari Germans Trias i Pujol, Badalona, Spain followed with a talk on: Personalized Therapies for Lung Cancer. Hiromi Sakamoto, also from the Center for Medical Genomics, National Cancer Center Research Institute, Japan discussed her group's work in the talk Whole Genome Association Studies for diffuse gastric cancer in Japan. The final talk of the morning was "Quo Vadis Genome" by Juergen Reichardt of the School of Medical Sciences, University of Sidney, Australia.
The talks and the ensuing discussion highlighted various aspects of the future of Predictive and Personalized Medicine of Cancer. Each speaker described a very different area of research but all of them referred to one or several other areas and the need for multidisciplinary teams and collaborations to achieve innovative therapies. The differences between populations was a common theme and the need for more DNA banks and published data on susceptibility in different populations and cohorts was discussed.